CYP2C9/CYP2C19-IN-1
Cat. No.：YN252076
| 产品名称: | CYP2C9/CYP2C19-IN-1 |
| CAS No.: | 1613465-33-0 |
| Chemical Name: | 2-[(E)-(1,4-dimethyl-2-piperazinylidene)amino]-5-nitro-N-phenyl-benzamide |
| Synonyms: | |
| 分子量: | 367.4 |
| 分子式: | C19H21N5O3 |
| SMILES: | CN1CCN(C)C/C1=N\C2=C(C(NC3=CC=CC=C3)=O)C=C([N+]([O-])=O)C=C2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | ML336 是一种喹唑啉酮类的委内瑞拉马脑炎病毒 (VEEV) 抑制剂，对 VEEV TC-83 CPE、VEEV V3526 CPE、VEEV 野生型 CPE 的IC50分别为 32、20 和 42 nM。ML336有效抑制 VEEV 诱导的三种病毒株 (TC-83、V3526 和野生型) 细胞病变效应。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Chung, D., Schroeder, C.E., Sotsky, J., et al.ML336: Development of quinazolinone-based inhibitors against Venezuelan Equine Encephalitis Virus (VEEV),1-27(2012)
